apn1
Species | Cat.# | Product name | Source (Host) | Tag | Protein Length | Price |
---|---|---|---|---|---|---|
S. cerevisia | APN1-1539S | Recombinant S. cerevisia APN1 protein | E.coli | N/A |
- Q&As
- Reviews
Q&As (19)
Ask a questionThe of APN1 is mainly able to bind to certain proteins to play an anti-inflammatory and immunomodulatory role.
The treatment of recombinant APN1 protein in some diseases requires strict dose control to avoid adverse reactions.
The efficacy of recombinant APN1 protein will vary depending on individual patient and disease state.
Recombinant APN1 protein has broad application prospects in hepatitis therapy, which can improve the therapeutic effect by regulating the immune system.
APN1 requires a doctor's prescription and supervised use by a professional doctor.
Because the APN1 can regulate the immune system, it has a good immunotherapy effect.
Recombinant APN1 protein can be applied in immunotherapy, tumor therapy, digestive system disease treatment, cardiovascular disease treatment and other fields.
The recombinant APN1 protein can be used by injection, oral or topical application.
The pharmacological action of APN1 is to play an anti-inflammatory and immunomodulatory role by regulating the activity of immune cells and promoting cell apoptosis.
The preparation method of APN1 includes genetic engineering technology and biological fermentation technology.
The use period of APN1 needs to be determined on a case-by-case basis.
The dose and frequency of use of APN1 need to be determined according to the treatment needs and the patient's condition.
APN1 has been applied in clinical treatment, and has achieved certain therapeutic effect.
The APN1 does not prevent disease and is only used as a treatment.
Current studies have shown that the APN1 can be used to treat some cancers, but its efficacy needs to be further studied.
APN1 is not currently an alternative to traditional therapies, but can be used as an adjunct therapy.
At present, the APN1 has been approved for use in the United States, the European Union, South Korea and other countries.
The APN1 is a of the human APN1 (enterase) gene, which is mainly used in the study of therapies targeting APN1.
Clinical trials have shown that the APN1 has a significant effect in the treatment of immune diseases, mouth ulcers and scarring.
Customer Reviews (3)
Write a reviewAPN1 has been demonstrated in a variety of application scenarios, maintaining stable performance regardless of changes in concentration, temperature, pH.
APN1 has strong anti-pollution ability, which effectively avoids the pollution problem in the experiment.
The production process of APN1 focuses on sustainable development, which brings considerable economic benefits to the company, while also protecting the planet.
Ask a Question for All apn1 Products
Required fields are marked with *
My Review for All apn1 Products
Required fields are marked with *